1800 244 735

Helpline (02) 9874 9777

Coming soon: HD Therapeutics Conference 2012

An oasis of hope in the desert: the annual Huntington’s Disease Therapeutics Conference in Palm Springs, California, begins on 27th February. We’ll be bringing you live updates via Twitter and the web.

An exciting time

If 2011 is anything to go by, we predict that 2012 will be a big year for Huntington’s disease treatment research.

The new year has already brought exciting news of gene silencing success in primate trials and striking improvement in HD mice from injection of the ‘brain fat’ GM1.

Annual Therapeutics Conference

For the last 7 years the annual HD Therapeutics Conference in Palm Springs, California, has been a significant occasion for HD drug-hunters. It’s where the most exciting and cutting-edge treatment research is announced and discussed. It’s also a gathering of the world’s top HD researchers where ideas are shared and fruitful collaborations formed and nurtured.

The Conference begins very soon – Monday 27th February, to be exact. Your intrepid HDBuzz reporters Ed Wild and Jeff Carroll are going undercover at the Conference to bring you the latest news and buzz from the meeting.

The inside scoop from HDBuzz

Each day, we’ll be tweeting live updates from 9am to 6pm Pacific Time (that’s roughly 5pm to 2am in Europe). Follow @HDBuzzFeed on Twitter now, so you don’t miss anything.

If you prefer a daily digest, check HDBuzz.net or any of the HD sites that carry HDBuzz syndicated content. Each day’s news will be gathered together into a new article each evening, with our ever-popular ‘sunset conclusions’ to put things in context.

In the coming weeks, we’ll also bring you featured stories and interviews with some top scientists from the Conference.

Get in touch!

We want to hear from you, too, so send your questions, comments and queries to palmsprings@hdbuzz.net or tweet @HDBuzzFeed now or throughout the Conference.

So, get following, sign up for email updates and check the web frequently. Here’s looking forward to an inspiring Therapeutics Conference.

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest Research Articles

Scientists identify precisely how pridopidine works in models of Huntington’s disease

Published date: 12 June, 2021

Pridopidine is a drug developed to treat Huntington’s disease (HD) and now scientists have a clearer understanding of how it works in the body and brain. In a series of academic papers, researchers figured out that pridopidine is working by targeting a particular receptor protein called S1R. With this new understanding, the researchers believe pridopidine ... Read more

Huntington's disease therapeutics conference 2021 – Day 3

Published date: 29 April, 2021

We are back for the last day of the virtual 2021 CHDI Therapeutics conference. This article summarises our live Twitter updates on the exciting science being presented, which you can find with the hashtag #HDTC2021. The final session of the conference will provide the latest news on more Huntington’s disease clinical programs. A new way ... Read more

Huntington's disease therapeutics conference 2021 – Day 2

Published date: 28 April, 2021

We are back with Day 2 of the virtual 2021 CHDI Therapeutics conference. This article summarises our live Twitter updates on the exciting science being presented, which you can continue to follow with the hashtag #HDTC2021. The morning session focussed on promising HD therapeutics that are in preclinical development and the afternoon session covered different ... Read more

Huntington’s disease therapeutics conference 2021 – Day 1

Published date: 28 April, 2021

The CHDI Therapeutics Conference 2021 kicked off today. This article summarizes our live Twitter updates on the exciting science being presented, which you can continue to follow with the hashtag #HDTC2021. The morning of Day 1 focused on clinical trial updates, while the afternoon explored genetic modifiers of HD and how they might be harnessed ... Read more

Huntington’s disease clinical trial round up

Published date: 26 April, 2021

It seems like the HD community has been inundated with updates from different companies and clinical trials recently. The news is far from complete doom and gloom; although there have been some real disappointments from some of the frontrunner trials, there are also positive updates from many different companies and lots of reasons for us ... Read more

Good news from uniQure: gene therapy trial on track, and promising data in animals

Published date: 15 April, 2021

Two recent press releases from uniQure provide welcome good news: the first ever HD gene therapy, known as AMT-130, has been administered via brain surgery to a small set of participants in an early safety trial. At the same time, uniQure has published findings in HD animal models that increase confidence in the drug’s ability ... Read more